Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: flame retardant

May 19, 2026 CD derivatives / Non-pharma applications / Other industrial use

Cyclodextrin and its derivatives for the structural regulation of epoxy resins: Chemistry, mechanisms, and emerging applications

This paper provides a comprehensive review of the research progress on cyclodextrin and polycarbonate in epoxi resin matrix materials. Specifically,

Continue reading

pexels-photo-30620861.jpeg
March 17, 2026 CD derivatives / Non-pharma applications / Other industrial use

Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application

Hewlett-Packard has developed a multi-fluid kit for three-dimensional printing, comprising:– a fusing agent including: – an electromagnetic energy absorber; and

Continue reading

June 16, 2022 Non-pharma applications / Other industrial use

Microfibrous cyclodextrin boosts flame retardancy of poly(lactic acid) II – phosphorous silane treatment further enhances the effectivity

Recently, the flame retardant effectiveness of a 2-hydroxypropyl-β-cyclodextrin (CD) type bio-based carbonising agent has been evinced to noticeably increase when

Continue reading

June 29, 2019 Other industrial use

Cyclodextrins as flame retardants

The intumescent flame retardants (IFRs) are one of widely used halogen-free flame retardants due to their advantages of little smoke

Continue reading

July 25, 2018 CD derivatives

Cyclodextrin Phosphates

In order to develop cyclodextrin derivatives having improved aqueous solubility, high solubilizing power, and low accumulation upon longer administration charged

Continue reading

Recent Posts

  • Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress
  • CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation
  • Nanotechnology World Conference 2026
  • Hybrid Cyclodextrin Nanosponges Meet Nanoporous Gold: A Step Forward in Sensing Platforms
  • Innovative Cyclodextrin Composition for Canine Odour Neutralization

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (345)
  • CD derivatives (408)
  • Cosmetics and toilettry (50)
  • Diagnosis (12)
  • Drug delivery (786)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (221)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (397)
  • Other industrial use (106)
  • Pharma applications (1,175)
  • Supramolecular systems (40)
  • Uncategorized (144)

Top Posts

  • Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress
  • CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation
  • Recent Advances in Intranasal Administration for Brain-Targeting Delivery
  • The story of cyclodextrin metal–organic frameworks and their applications from Nobel-prize laureate, F. Stoddart
  • Improving Drug Bioavailability with Cyclodextrin Complexes: An integrative meta-modeling approach
  • Innovative Cyclodextrin Composition for Canine Odour Neutralization
  • Lanosterol eye drops for cataract treatment
  • One-pot synthesis of γ-cyclodextrin of high purity from non-food cellulose without the use of complexing agents
  • Hybrid Cyclodextrin Nanosponges Meet Nanoporous Gold: A Step Forward in Sensing Platforms
  • Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers

Loading Comments...